(Q37212028)

19 August 2017

1 reference

title

Diabetes classification: grey zones, sound and smoke: Action LADA 1. (English)

1 reference

19 August 2017

R D G Leslie

1

1 reference

19 August 2017

H Kolb

2

1 reference

19 August 2017

N C Schloot

3

1 reference

19 August 2017

R Buzzetti

4

1 reference

19 August 2017

D Mauricio

5

1 reference

19 August 2017

A De Leiva

6

1 reference

19 August 2017

K Yderstraede

7

1 reference

19 August 2017

C Sarti

8

1 reference

19 August 2017

C Thivolet

9

1 reference

19 August 2017

D Hadden

10

1 reference

19 August 2017

S Hunter

11

1 reference

19 August 2017

G Schernthaner

12

1 reference

19 August 2017

W Scherbaum

13

1 reference

19 August 2017

R Williams

14

1 reference

19 August 2017

P Pozzilli

15

1 reference

19 August 2017

publication date

1 October 2008

1 reference

Diabetes - Metabolism: Research and Reviews

19 August 2017

published in

1 reference

19 August 2017

volume

24

1 reference

19 August 2017

issue

7

1 reference

19 August 2017

page(s)

511-519

1 reference

Follow-up report on the diagnosis of diabetes mellitus

19 August 2017

cites work

1 reference

7 January 2021

Activating mutations in Kir6.2 and neonatal diabetes: new clinical syndromes, new scientific insights, and new therapy

1 reference

7 January 2021

Latent autoimmune diabetes in adults: a guide for the perplexed

1 reference

7 January 2021

Phenotypic heterogeneity between different mutations of MODY subtypes and within MODY pedigrees

1 reference

7 January 2021

Diabetic ketoacidosis in Denmark Incidence and mortality estimated from public health registries.

1 reference

7 January 2021

Accuracy and predictive value of classification schemes for ketosis-prone diabetes

1 reference

7 January 2021

Immunogenetic analysis suggests different pathogenesis for obese and lean African-Americans with diabetic ketoacidosis

1 reference

7 January 2021

Ketosis-prone type 2 diabetes in patients of sub-Saharan African origin: clinical pathophysiology and natural history of beta-cell dysfunction and insulin resistance

1 reference

7 January 2021

Metabolic and immunogenetic prediction of long-term insulin remission in African patients with atypical diabetes.

1 reference

7 January 2021

GAD antibody negative NIDDM in adult black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4. Flatbush diabetes

1 reference

7 January 2021

Pathophysiology of ketoacidosis in Type 2 diabetes mellitus

1 reference

7 January 2021

Ketosis-prone type 2 diabetes: time to revise the classification of diabetes

1 reference

7 January 2021

Genomics and medicine. Dissecting human disease in the postgenomic era.

1 reference

7 January 2021

What is cystic fibrosis?

1 reference

7 January 2021

Nonclassic cystic fibrosis: a clinical conundrum

1 reference

7 January 2021

Clinical review: Type 1 diabetes and latent autoimmune diabetes in adults: one end of the rainbow

1 reference

7 January 2021

Genetic, autoimmune, and clinical characteristics of childhood- and adult-onset type 1 diabetes

1 reference

7 January 2021

Age-dependent influences on the origins of autoimmune diabetes: evidence and implications

1 reference

7 January 2021

An association analysis of the HLA gene region in latent autoimmune diabetes in adults.

1 reference

7 January 2021

Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43)

1 reference

7 January 2021

Ketosis-prone diabetes: dissection of a heterogeneous syndrome using an immunogenetic and beta-cell functional classification, prospective analysis, and clinical outcomes

1 reference

7 January 2021

Heterozygosity for MICA5.0/MICA5.1 and HLA-DR3-DQ2/DR4-DQ8 are independent genetic risk factors for latent autoimmune diabetes in adults

1 reference

7 January 2021

MICA is associated with type 1 diabetes in the Belgian population, independent of HLA-DQ

1 reference

7 January 2021

MICA marks additional risk factors for Type 1 diabetes on extended HLA haplotypes: An association and meta-analysis

1 reference

7 January 2021

The Variable Number of Tandem Repeats Upstream of the Insulin Gene Is a Susceptibility Locus for Latent Autoimmune Diabetes in Adults

1 reference

7 January 2021

Autoantibodies as predictors of disease

1 reference

7 January 2021

Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk

1 reference

7 January 2021

UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes

1 reference

7 January 2021

IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71).

1 reference

7 January 2021

GAD autoantibodies and epitope reactivities persist after diagnosis in latent autoimmune diabetes in adults but do not predict disease progression: UKPDS 77

1 reference

7 January 2021

Diabetes Antibody Standardization Program: First Assay Proficiency Evaluation

1 reference

7 January 2021

Latent autoimmune diabetes in adults (LADA) should be less latent

1 reference

7 January 2021

1 reference

7 January 2021

Is latent autoimmune diabetes in adults distinct from type 1 diabetes or just type 1 diabetes at an older age?

1 reference

7 January 2021

Immunological heterogeneity in type I diabetes: presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease

1 reference

7 January 2021

GAD65 Antibody Epitope Patterns of Type 1.5 Diabetic Patients Are Consistent With Slow-Onset Autoimmune Diabetes

1 reference

7 January 2021

Autoantibody profile and epitope mapping in latent autoimmune diabetes in adults

1 reference

7 January 2021

Recombinant Fabs of human monoclonal antibodies specific to the middle epitope of GAD65 inhibit type 1 diabetes-specific GAD65Abs

1 reference

7 January 2021

Epitope analysis of insulin autoantibodies using recombinant Fab.

1 reference

7 January 2021

IgG4-subclass of glutamic acid decarboxylase antibody is more frequent in latent autoimmune diabetes in adults than in type 1 diabetes.

1 reference

7 January 2021

High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes.

1 reference

7 January 2021

Cellular immune responses to human islet proteins in antibody-positive type 2 diabetic patients.

1 reference

7 January 2021

Increased risk for endocrine autoimmunity in Italian type 2 diabetic patients with GAD65 autoantibodies

1 reference

7 January 2021

Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.

1 reference

7 January 2021

Gliadin, endomysial and thyroid antibodies in patients with latent autoimmune diabetes of adults (LADA).

1 reference

7 January 2021

An immune origin of type 2 diabetes?

1 reference

7 January 2021

Insulin resistance and the metabolic syndrome--or the pitfalls of epidemiology

1 reference

7 January 2021

Raised C-reactive protein levels in patients with recent onset type 1 diabetes

1 reference

7 January 2021

Type 1 diabetes is associated with increased cyclooxygenase- and cytokine-mediated inflammation

1 reference

7 January 2021

CRP and IL-6 concentrations are associated with poor glycemic control despite preserved beta-cell function during the first year after diagnosis of type 1 diabetes

1 reference

7 January 2021

An Association of Autoantibody Status and Serum Cytokine Levels in Type 1 Diabetes

1 reference

7 January 2021

The heterogeneity of diabetes: unraveling a dispute: is systemic inflammation related to islet autoimmunity?

1 reference

7 January 2021

Comparison of clinical and laboratory characteristics between adult-onset type 1 diabetes and latent autoimmune diabetes in adults

1 reference

7 January 2021

Beta-cell function in relation to islet cell antibodies during the first 3 yr after clinical diagnosis of diabetes in type II diabetic patients.

1 reference

7 January 2021

Insulin resistance in latent autoimmune diabetes of adulthood

1 reference

7 January 2021

Phenotypic characteristics of GAD antibody-positive recently diagnosed patients with type 2 diabetes in North America and Europe

1 reference

7 January 2021

Equivalent insulin resistance in latent autoimmune diabetes in adults (LADA) and type 2 diabetic patients

1 reference

7 January 2021

Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study).

1 reference

7 January 2021

Haemophilias A and B.

1 reference

7 January 2021

Islet autoantibodies in clinically diagnosed type 2 diabetes: prevalence and relationship with metabolic control (UKPDS 70).

1 reference

7 January 2021

Insulin intervention to preserve beta cells in slowly progressive insulin-dependent (type 1) diabetes mellitus

1 reference

7 January 2021

Rosiglitazone combined with insulin preserves islet beta cell function in adult-onset latent autoimmune diabetes (LADA).

1 reference

7 January 2021

Clinical evidence for the safety of GAD65 immunomodulation in adult-onset autoimmune diabetes

1 reference

7 January 2021

A new expression of diabetes: double diabetes

1 reference

7 January 2021

Identifiers

DOI

10.1002/DMRR.877

1 reference

19 August 2017

1 reference